FY2012 · ended Dec 31, 2012 · Revenue $28.56M, +19.8% YoY · Filed Apr 15, 2013
Tanke Biosciences Corp (TNBI) files with the SEC under industry code 2040, Grain Mill Products. In fiscal 2012, which ended Dec 31, 2012, it reported revenue of $28.6 million and a net loss of $210,247. Free cash flow was -$2.0 million. As of Sep 30, 2013 it held $5.1 million in cash and investments and $1.9 million in total debt.
Revenue (TTM)
$22.96M
-19.5% vs year-ago TTM
Net income (TTM)
$-1.64M
-164.1% vs year-ago TTM
Operating cash flow (TTM)
$-3.64M
-179.8% vs year-ago TTM
Free cash flow (TTM)
$-6.13M
-273.3% vs year-ago TTM
EPS
$-0.24
Dividend per share
None
Shares outstanding
13.32M
+0.0% vs prior year
Net cash
$3.18M
as of Sep 30, 2013
Operating margin
-0.2%
FY 2013
Company profile
- Industry
- Grain Mill Products (SIC 2040)
- Listed as
- TNBI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Pearl River New City Guangzhou, China
- SEC CIK
- 1452011
- Former names
- GREYHOUND COMMISSARY, INC. (until Feb 3, 2011)
Other Grain Mill Products companies
- General Mills Inc GIS
- Ingredion Inc INGR
- Post Holdings, Inc. POST
- Freshpet, Inc. FRPT
- Forafric Global PLC AFRI
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2012 Dec 31, 2012 |
FY 2011 Dec 31, 2011 |
|---|---|---|
| Revenue | $28.6M | $23.8M |
| Operating income | $4.5M | $1.7M |
| Net income | -$210,247 | -$3.1M |
| Diluted EPS | — | -$0.24 |
| Operating cash flow | -$1.2M | $3.7M |
| Free cash flow | -$2.0M | $3.0M |
| Total assets | $28.8M | $24.9M |
| Total liabilities | $12.9M | $9.0M |
| Stockholders' equity | $15.8M | $15.9M |
| Cash and investments | $6.2M | $7.7M |
| Total debt | $2.1M | $1.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Auditor change
|
Dec 26, 2013 | Dec 19, 2013 |
| 8-K | Current report | Nov 22, 2013 | Sep 30, 2013 |
| 10-Q | Quarterly report | Nov 14, 2013 | Sep 30, 2013 |
| 8-K |
Current report
Officer or director change
|
Oct 4, 2013 | Sep 30, 2013 |
| 8-K |
Current report
Material agreement
|
Aug 29, 2013 | Aug 23, 2013 |
| 10-Q | Quarterly report | Aug 14, 2013 | Jun 30, 2013 |
All 127 Tanke Biosciences Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.